AAAAAA
Results: 26-30/30
Authors:
Menard, S
Casalini, P
Tomasic, G
Pilotti, S
Cascinelli, N
Bufalino, R
Perrone, F
Longhi, C
Rilke, F
Colnaghi, MI
Citation: S. Menard et al., Pathobiologic identification of two distinct breast carcinoma subsets withdiverging clinical behaviors, BREAST CANC, 55(2), 1999, pp. 169-177
Authors:
Lauria, R
Ferrari, E
Tramontana, S
Morabito, A
Perrone, F
Maffeo, A
Fiorentino, R
Casella, G
Iodice, F
Ricchi, P
Carlomagno, C
Varriale, E
De Placido, G
De Placido, S
Bianco, AR
Pignata, S
Citation: R. Lauria et al., A phase I study of paclitaxel and epirubicin, without and with filgrastim,for the treatment of platinum-resistant advanced ovarian cancer, ONCOL-BASEL, 56(4), 1999, pp. 267-273
Authors:
Ruckdeschel, JC
Gridelli, C
Perrone, F
Monfardini, S
Giaccone, G
Citation: Jc. Ruckdeschel et al., Pro: Are platinum compounds mandatory in the treatment of metastatic non-small cell lung cancer?, EUR J CANC, 34(13), 1998, pp. 1993-1995
Authors:
Gridelli, C
Perrone, F
Monfardini, S
Citation: C. Gridelli et al., Contra: Are platinum compounds mandatory in the treatment of metastatic non-small cell lung cancer?, EUR J CANC, 34(13), 1998, pp. 1995-1997
Authors:
Bakalov, D
Brandi, F
Cantatore, G
Carugno, G
Carusotto, S
Della Valle, F
De Riva, A
Gastaldi, U
Iacopini, E
Micossi, P
Milotti, E
Onofrio, R
Pengo, R
Perrone, F
Petrucci, G
Polacco, E
Rizzo, C
Ruoso, G
Zavattini, E
Zavattini, G
Citation: D. Bakalov et al., The measurement of vacuum polarization: The PVLAS experiment, HYPER INTER, 114(1-4), 1998, pp. 103-113